Navigation Links
Poverty May Aggravate Asthma
Date:11/10/2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...MUS, N.J., Dec. 4 Movado... & Co. Jewelers, Atlanta, Georgia, shared in a... Open quarterfinalist Melanie Oudin for her stella...e youngest American quarterfinalist at the Open si...cgi-bin/prnh/20091204/NY21184 ) ,, At a celebra...
(Date:12/4/2009)...FFERSON CITY, Mo., Dec. 4 Farmers ...rosetti, State Fire Marshal Randy Cole, and Brad B...afety program sponsored by Farmers called FireFa... at the Missouri Capitol December 9. ,, (Logo...ATH062 ) ,, "The call for fire safety comes fol...
(Date:12/4/2009)...INGTON, Dec. 4 The foll... the Heinz Family Philanthropies: ,, Credit Sen...th a significant contribution to the health care d...Americans living with Phenylketonuria (PKU) contro...ay others living with serious chronic conditions a...
(Date:12/4/2009)...lished this week in the Journal of Neurosurgery: ...g Juvenile Pilocytic Astrocytoma, or JPA, tumors i...Diffusion Tensor Imaging, or DTI. The sensitivity...rve fiber bundles in the brain. This information ...the tumor while avoiding damage to the fiber bundl...
(Date:12/4/2009)...ofile usually conveys true personality, study find... Does your profile on an online social network, su...good that it does, reports a new study, which find...stead of idealized identities. , "I was surpri...tion is that people are using their profiles to pr...
Breaking Medicine News(10 mins):Health News:Missouri Safety Day at the Capitol 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 2Health News:Health Leadership from Sen. Kerry and Sen. Casey: A Cure for Devastating Discrimination in Insurance Coverage for PKU Patients is on the Move 3Health News:Online Identities Likely to Match Reality 2
...y College London and Imperial College London have ...sy environment, such as a pub or in a crowd. // Th...ain work together to make sense of what it hears, ...perience of people who rely on cochlear implants, ...
...tting ready to go home. Savage, who received ...mber last, says he feels sensation in his// new li...and in a ghastly machine press accident. Savag...ansplant surgeries. Savage, who reported sensa...
...r educated about the risks of exposing children to...h researchers.// Results from a 14-year stu...e more likely to suffer respiratory problems. ...rn Australia say the evidence supports a ban on sm...
...ommended a maximum residue limit (MRL) of one part... the panel has suggested that the limit should be ...nsumer safety. The panel is headed by the ch...f a controversy over pesticide residues in colas. ...
... issue in quality of life for patients with chroni...peaker, advocate and rheumatology patient, is// ou...nals address this aspect of care. During an hour-l... experiences. Perhaps most importantly, she’ll be ...
...rs seem to have tapped nature, in the form of an e...a possible cure for a notorious type of childhood/...a accounts for nearly 3% of all cancers in childre...'Brien of the University of California, San Franci...
Other Medicine News:Health News:Making Sense of the World Through a Cochlear Implant 2Health News:Destroying Taboos to Improve Patient Care 2
(Date:12/3/2009)...c. 3 Radiology imaging leader MEDR...ration capabilities at the November 2009 Radiology...t.PACS(TM) product, enabling the first radiology ...t release in the company,s newly branded Certegra...://www.newscom.com/cgi-bin/prnh/20091203/NE20631 ...
(Date:12/3/2009).... 3 Wound Management...rapidly growing provider of specialty medical prod... Industry Representative Association (HIRA) to ser...ing representative to market the company,s core Ce...IRA will market and sell Wound Management Technolo...
(Date:12/3/2009)...re-FirstCall/ -- Cardium Therapeutics (NYSE Amex: ...diary, Tissue Repair Company, submitted a 510(k) p...d Drug Administration (FDA) seeking marketing clea...sed on positive data from the Company,s recently c...submission with the FDA covers Excellagen XL(TM) ...
Breaking Medicine Technology:MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 2Wound Management Technologies, Inc. Signs Agreement with Major Sales Representative Organization for Increased Marketing of CellerateRx(R); Third Quarter Sales Up 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 1Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 2Sigma Aldrich Acquires ChemNavigator Inc to Provide Researchers With Industry Leading Chemical Compound Selection and Procurement Services 13431 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 1SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 2SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 3SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 4SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 5SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 6SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 7SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 8SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 9SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights 13427 10Combo Treatment May Ease Depression After Stroke 53891 1Combo Treatment May Ease Depression After Stroke 53891 2
TME 228 TS
TME 63 TC
TME 66 S
TME 64 S-3
Medicine Products: